Related references
Note: Only part of the references are listed.Extended follow-up of a phase 3 trial in relapsed multiple myeloma:: final time-to-event results of the APEX trial
Paul G. Richardson et al.
BLOOD (2007)
The high incidence of varicella herpes zoster with the use of bortezomib in 10 patients
Yin Tong et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma:: results of a multicenter phase 1/2 study
Maria-Victoria Mateos et al.
BLOOD (2006)
Immune parameters in multiple myeloma patients:: Influence of treatment and correlation with opportunistic infections
Philipp Schuett et al.
LEUKEMIA & LYMPHOMA (2006)
Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation
Alessio Nencioni et al.
BLOOD (2006)
Bortezomib after dose-reduced allogeneic stem cell transplantation for multiple myeloma to enhance or maintain remission status
Nicolaus Kroeger et al.
EXPERIMENTAL HEMATOLOGY (2006)
Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines
B Blanco et al.
BLOOD (2006)
Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells
A Nencioni et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma
PG Richardson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Preventing varicella-zoster disease
S Hambleton et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma
S Jagannath et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib
K Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Glucocorticoids and invasive fungal infections
MS Lionakis et al.
LANCET (2003)
A phase 2 study of bortezomib in relapsed, refractory myeloma
PG Richardson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Clinical and molecular pathogenesis of varicella virus infection
DH Gilden et al.
VIRAL IMMUNOLOGY (2003)
Thalidomide as an anti-cancer agent
S Kumar et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2002)
Share Paper
